{name}
{subtitle}
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~11 mi. (Mannheim, Germany, +201 more cities)
facility
Universitatsklinikum Mannheim /ID# 221172
drug
azacitidine, +1 more drug
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~11 mi. (Mannheim, Germany, +197 more cities)
facility
Universitatsklinikum Mannheim /ID# 239762
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
drug
azacitidine, +1 more drug
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~11 mi. (Mannheim, Germany, +165 more cities)
facility
Universitatsklinikum Mannheim /ID# 221523
biomarker
del(11)(q10), +27 more biomarkers
drug
navitoclax, +1 more drug
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~26 mi. (Heidelberg, Germany, +151 more cities)
facility
GSK Investigational Site
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~26 mi. (Heidelberg, Germany, +145 more cities)
facility
Universitaetsklinikum Heidelberg. ( Site 1204)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types